CORVUS PHARMACEUTICALS INC. - COMMON STOCK
9.1900
25-November-24 12:24:38
15 minutes delayed
Stocks
+0.2400
+2.68%
Today's range
8.9550 - 9.3529
ISIN
N/A
Source
NASDAQ
-
25 Oct 2022 16:05:00 By Nasdaq GlobeNewswire
-
26 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the H.C. Wainwright 24th Annual Global Investment Conference
06 Sep 2022 16:05:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Second Quarter 2022 Financial Results
08 Aug 2022 16:05:01 By Nasdaq GlobeNewswire
-
28 Jul 2022 16:05:01 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Appoints Dr. James Rosenbaum Senior Vice President of Research
21 Jul 2022 16:05:01 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Program Updates at R&D Symposium
10 May 2022 07:30:02 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2022 Financial Results
05 May 2022 16:05:03 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Host R&D Symposium on May 10, 2022 in New York
26 Apr 2022 07:30:00 By Nasdaq GlobeNewswire
-
10 Mar 2022 16:05:01 By Nasdaq GlobeNewswire
-
03 Mar 2022 16:30:00 By Nasdaq GlobeNewswire
-
13 Jan 2022 18:30:00 By Nasdaq GlobeNewswire
-
13 Dec 2021 09:00:00 By Nasdaq GlobeNewswire
-
12 Nov 2021 07:00:02 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals to Present at the Jefferies London Healthcare Conference
10 Nov 2021 16:05:00 By Nasdaq GlobeNewswire
-
02 Nov 2021 16:05:01 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2021 Financial Results
01 Nov 2021 16:05:00 By Nasdaq GlobeNewswire
-
27 Oct 2021 16:05:01 By Nasdaq GlobeNewswire
-
22 Sep 2021 06:00:00 By Nasdaq GlobeNewswire
-
Corvus Pharmaceuticals Announces Participation in Upcoming Investor Conferences
07 Sep 2021 16:05:00 By Nasdaq GlobeNewswire